Liberty Health Sciences Inc. (OTCMKTS:LHSIF) Introduces New Product Brand In Florida and Provides Update on COVID-19 Response

Liberty Healthy Sciences Inc. (OTCMKTS:LHSIF) has announced an expansion of its brand portfolio of high-quality products that are currently available in various locations across Florida.

Liberty expands its product portfolio in Florida with the addition of a new brand

The company has introduced the Liberty Health Sciences Shake brand as part of its growing portfolio that comprises innovative cannabis formulations and products, CBD topicals, premium flower, vape products, extracts, and tinctures. Liberty has been expanding its portfolio, and recently it launched the Clarity Brands that comprises of oil derived cannabis products on G Pen pods and cartridges. Also, the company added Papa’s Herb Classic 510 pen to the Papa’s Herb brand that has grown in popularity in its dispensaries.

The company’s CEO Victor Mancebo indicated that they are looking forward to enhancing their product offering and establish ways of meeting patient needs. Mancebo added that the company is focused on providing accessible premium products to consumers at competitive prices, especially during the current times.

Update on response to COVID-19

Recently the company offered an update regarding its response to the coronavirus and the progress of its main business amid the COVID-19 pandemic. The company’s management is dedicated to ensuring the safety and well-being of its employees, patients, and customer through adherence if the directives and guidance offered by the CDC to combat the spread of COVID-19.

Liberty’s dispensaries have remained open across Florida amid the pandemic during scheduled hours and continued serving patients that depend on its premium and valued products for improved quality of life and wellness. Similarly, the company has implemented sanitary measures in its delivery vehicles and dispensaries.

The CEO indicated that despite the current crisis, the company has grown to be a string business compared to a year ago. This is because of the expansion of the company’s market presence, enduring partnerships, and growing portfolio of proprietary product offerings. He added that the closure of local municipality offices because of COVID-19 has delayed new retail store openings that were expected by the end of the first quarter of FY2021.


Liberty Health Sciences Inc (OTCMKTS:LHSIF) Launches Dispensary In Miami

Liberty Health Sciences Inc (OTCMKTS:LHSIF) is a business guru focusing in the production and sale of medical cannabis. The company undertakes most of its business operations through DFMMJ LLC. This happens to be one of its top-performing subsidiaries. It has its headquarters in Vancouver. The business has today disclosed details about its plan to set up a new dispensary in Miami.

Current state of affairs

The company establishes its dispensary on Bird Road and market observers have applauded the latest move. Miami-Dade County is one of the highly populated counties in Miami. Reports indicate that is a new dawn for customers in this particular zone. They get to enjoy quick access to top-quality educational services and medical marijuana products.

An official working with the company says that this dispensary will serve customers every day. However, on Saturday and Sunday the opening times won’t be the same as the ones for the weekdays. Bird Road has been operational for over quite a long period of time and has been one of the busiest. It links Kendall, Westchester, South Miami, West Miami and oral Gables.

There are also plans underway to launch three more dispensaries this month. If all moves according to plan, the company will launch more over the coming year. The Florida Department of Health has a part to play. It is the one to give the required approvals.

A close outlook

George Scorsis, current CEO of the company in a recent statement outlined that they have major plans underway. According to him, they intend to make their marijuana products easily accessible to the large number of customers.

The leader says that they remain dedicated to serving customers with top quality medicinal cannabis. The official says they have the best brands in store and that customers are free to visit and make purchases. They have Mary’s Medicinals products and PAX products in store.

Scorsis opined, “No other company has a brand-house and selection like ours. This demonstrates that not only do our partner brands trust and believe in us to deliver against their goals and objectives, but that consumers also have a diverse selection of the best products available.”

Marijuana Medical

Liberty Health Sciences Inc (OTCMKTS:LHSIF) To Strike A Partnership Targeted At Boosting Crop Output

Liberty Health Sciences Inc (OTCMKTS:LHSIF) has announced its collaboration with AdaViv Inc. The two are seeking to give a major boost to the production of cannabis. Experts have termed Liberty Health Sciences 360 Innovation Campus an ideal location that will see the company increase its output.

Turn of events

AdaViv seeks to integrate its Machine Learning platform and adaptive Computer Vision software in the production activities. The top-notch greenhouse technology will be an added advantage as the company seeks to boost its production capacity. The distinguishable attribute about AdaViv’s technology is that it facilitates effective and efficient plant-level inspection.

Liberty Health Sciences CEO George Scorsis opined, “Working together, we hope to refine AdaViv’s game changing data capture and growth analytics technology to help us achieve the highest quality, consistency and yield for our crops, as well as monitor our plants in ways that our eyes never could.”

This collaboration is a clear demonstration of the unwavering commitment by Liberty to become a trusted company that understands the real essence of establishing new ways to enhance common practices. Data and technology play a central role in this entire undertaking.

Hopefully, AdaViv will play its part by providing workable knowledge that will be supported by appropriate required data. It will be about giving a major boost to the output as well as the quality and that will of course be in the form of a data driven format.

Seiferling perspective

The current CEO of AdaViv Ian Seiferling is quite pleased about the collaboration with Liberty Health Sciences, a move targeted towards the development of new AI-driven analytics for the fast rising medicinal cannabis industry.

Scorsis is one of the officials that believe in taking cultivation with the seriousness that it deserves. He is one of the major supporters of the implementation of AdaViv since that is one of the best strategies to drive output a notch higher.

Liberty Health Sciences Inc has also expressed its excitement for having become the first PAX Era brand partner. This is basically a portable cannabis oil vaporizer which is quite easy to use. The business guru is looking forward to sell the PAX Era system in Florida and this is happening at a time when business competition is on the rise.


Liberty Health Sciences Inc (OTCMKTS:LHSIF) Cultivation Capacity Doubled After Expansion Of Innovation Campus

Liberty Health Sciences Inc (OTCMKTS:LHSIF) is reporting an increase in cultivations space in Florida thanks to the expansion of its Liberty Health Sciences 360 Innovation Campus. The campus, which is located in Gainesville was started to address the growing demand for cannabis products among patients in Florida.

The 360 Campus was started after the company secured regulatory approvals. The company is in the final stages of setting the facility to accommodate cannabis production activities.  Liberty Health Sciences’ facilitate located in Chestnut Hill is operating at optimal capacity.

Increasing production capacity

The company says the addition of the 20,000 sq. ft. will significantly increase its production capacity.  The new addition will bring the company’s total cultivation space to 41,200 sq. ft.  The first phase of the project will be used for cultivation premium quality cannabis.  The facility will also be sued to carry out Research and Development activities to support future genetic programs.

The second phase will involve retrofitting the facility, which is expected to be completed before end of this year. This phase is expected to add an additional 80,000 sq. feet of cultivation space.  With this space, Liberty will have the largest production capacity throughout Florida.   The company will have a total of 225,000 sq. feet.

Creating a cannabis cultivation ecosystem

The recently added cultivation space is function and controlled to maintain environmental standards. Some of the facilities installed include grow lighting, an irrigation system, CO2 dosing, air filtration exchange and heating and cooling system. With all these supporting amenities in place, the company is guaranteed of optimal production.

Liberty enters agreement with Aphria Inc

Recently, Aphria Inc entered into a stand-still agreement to sell its share in Liberty. The agreement was first announced in February as part of Aphria’s plan for listing on the Toronto Stock exchange. Aphria had entered into an agreement with buyers led by the Serruya family.  The group had expressed interest in buying Aphria’s shares in Liberty. The group was seeking shares that are not attached to the escrow requirements of the Canadian Stock Exchange.


Liberty Health Sciences Inc Intends To Bring Solei Cannabis Brand To Massachusetts And Florida

Liberty Health Sciences Inc (OTCMKTS:LHSIF) has disclosed everything regarding its move to sign an amended licensing agreement with Aphria Inc. And its aim is to give a major lift to the Company’s growing portfolio of brands through the addition of Solei Sungrown Cannabis (“Solei”).

Liberty’s Near-term goals

Liberty will under the terms of the agreement produce as well as sell Solei in Massachusetts and Florida and that will of course be after it fulfills all the requirements by the Florida Department of Health, Massachusetts Cannabis Control Commission and the Office of Medical Marijuana Use.

Market dynamics are shifting quite fast and most of the market observers around the globe attest to that. The company is doing all within its means to ensure that it remains relevant in the long run and at this moment it is quite pleased to be the one introducing Solei to the U.S. It is also working hard to ensure that it achieves its set goal of availing it to all the patients throughout Massachusetts and Florida.

Serving patients in need of access to an easy-to-understand format

The Director and CEO of Liberty George Scorsis sees Solei as the best complement to the patient-centric approach of Libertyto medical cannabis. Looking at the efforts being made at this point in time, it goes without saying that Solei will succeed on its quest to make medical cannabis understandable to each and every patient that needs to access an easy-to-understand format.

The plan at the moment is to make Solei available in the wide range of product consumption alternatives that pull along with the easy-to-use instructions targeted at simplifying cannabis use.

The CEO of Aphria Vic Neufeld opined, “Aphria is delighted to extend our strategic relationship with Liberty, as they continue to demonstrate leadership in Florida and soon other legal markets in the U.S. Medical cannabis patients in Florida and elsewhere will benefit from Solei’s uncomplicated and simplified approach to consuming cannabis, which really sets the brand apart in the marketplace.”

Marijuana has already been legalized in a number of states in the U.S and the process continues. It was sometime back unimaginable to think of marijuana as a safe household name, but we are there already.

Pin It on Pinterest